Clinical Trials Logo

Clinical Trial Summary

The Aging Mastery Program® (AMP) is designed to inform, encourage, and support older adults as they take steps to improve their lives and stay engaged in their communities. The program incorporates evidence-informed materials, expert speakers, group discussion, peer support, and small rewards to give participants the skills and tools they need to achieve measurable improvements in managing their health, remaining economically secure, and contributing actively to society. L.A. CAPRA in partnership with the National Council on Aging, City of Los Angeles and the Los Angeles County Department of Aging will evaluate the effectiveness of the AMP program across 5 community-based senior sites. The overall objective of the proposed study is to evaluate the effectiveness of AMP program on improving the health and well-being of older adults using a randomized wait-list controlled trial.


Clinical Trial Description

The Aging Mastery Program® (AMP) offers community-based organizations a clear path to engage older adults and address the physical, financial, and emotional wellness of older adults. First piloted nationally in five senior centers, AMP incorporates evidence-based materials, expert speakers, group discussion, and peer support to give participants the skills and tools they need to achieve measurable improvements in managing their health and remaining economically secure. The program aims to empower seniors to make and maintain small, impactful changes to their behaviors to live a healthier, happier, and more secure life. AMP has been field-tested in various rural and urban setting, senior centers, and across an ethnically diverse middle-aged and older adult population, reaching almost 6,000 since 2013. Currently, the program is being evaluated through a quasi-experimental study in New York State and under consideration as an evidence-based program.

The National Council on Aging study team will train six program leads from the City of Los Angeles Department of Aging and Los Angeles Area on Aging to implement Aging Mastery Program® (AMP). The intervention will consist of a 10-week series held once-a-week for an hour and half (90 minutes). It will be group-based and led by trained facilitators and designated expert speakers in a community-based setting (senior centers). The program reviews 10 central areas of aging (1) navigating longer lives, (2) physical activity, (3) sleep, (4) healthy eating and hydration, (5) financial security, (6) medication management, (7) advance care planning, (8) healthy relationships, (9) falls prevention, and (10) community engagement. The intervention is based in social cognitive theory and attribution retraining and incorporates elements such as verbal persuasion, goal setting, problem solving, and attribution retraining techniques that encourage students to adopt controllable and unstable explanations.

Study Participants (N=200 or n=40/site) will be recruited from 5 study sites to participate in the Aging Mastery Program. UCLA study personnel will be on-site to consent older adults to participate in the evaluation of intervention and take part of baseline and post-intervention assessments. Upon signing the consent, study staff will collect self-administered baseline data (measures and measurement tools --i.e. Patient Information Survey, PROMIS and Patient Activation Survey (PAM) from all participants (n=200). After baseline data has been collected, participants will be randomized and assigned to either the immediate intervention groups (n=100 intervention) or the wait-list control (n=100). At each site, forty participants will be in the intervention group and 40 will be in wait-list control. Following the 10-week Aging Mastery Program®, post-intervention assessment (measures and measurement tools --i.e. Patient Information Survey, Patient Satisfaction, PROMIS and PAM) will be administered. During the data collection sessions, study staff will go to community sites and collect post-treatment self-reported assessment ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03342729
Study type Interventional
Source University of California, Los Angeles
Contact
Status Completed
Phase N/A
Start date May 1, 2017
Completion date March 15, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1